Mineralocorticoid receptor antagonists (MRAs) vs placebo or no treatment
Heart failure hospitalisation (RR) · patients with chronic heart failure with preserved ejection fraction
Mineralocorticoid receptor antagonists (MRAs) probably leads to lower heart failure hospitalisation (RR) compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
- Beta‐blockers and inhibitors of the renin‐angiotensin aldosterone system for chronic heart failure with preserved… 2021 · Cochrane Headline outcomes onlyRR 0.82 [0.69, 0.98]3 studies · 3714 participantsModerate